Synthorx's Series C Round

Synthorx raised a round of funding on April 30, 2018.

Synthorx leverages a genetic alphabet platform that expands the chemical and structural repertoire of protein therapeutics and uncovers new ways to modulate pharmacological properties of biologics. Th…

Articles about Synthorx's Series C Round: